0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia

Jonathan Graff-Radford, MD1; Keith A. Josephs, MD, MST, MSc1; Joseph E. Parisi, MD1,2 ; Dennis W. Dickson, MD3; Caterina Giannini, MD, PhD2 ; Bradley F. Boeve, MD1
[+] Author Affiliations
1Department of Neurology, Mayo Clinic, Rochester, Minnesota
2 Department of Laboratory Medicine and Pathology (Neuropathology), Mayo Clinic, Rochester, Minnesota
3Department of Neuroscience, Neuropathology Laboratory, Mayo Clinic, Jacksonville, Florida
JAMA Neurol. 2016;73(1):123-125. doi:10.1001/jamaneurol.2015.2711.
Text Size: A A A
Published online

Extract

This case report describes a woman in her 60s who presented with progressive anomia with loss of word knowledge, prosopagnosia, and surface dyslexia.

Semantic variant primary progressive aphasia (svPPA) most often is due to TAR DNA-binding protein 43 (TDP-43) pathology.1 Herein, we report a case of svPPA due to a globular glial tauopathy (GGT).

Article InformationCorresponding Author: Bradley F. Boeve, MD, Mayo Clinic, 200 1st St SW, Rochester, MN 55905 (bboeve@mayo.edu).

Published Online: November 16, 2015. doi:10.1001/jamaneurol.2015.2711.

Author Contributions: Dr Graff-Radford had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors reviewed the manuscript and were in agreement with its content and provided final approval of the version to be published.

Study concept and design: Graff-Radford, Josephs, Parisi, Boeve.

Acquisition, analysis, or interpretation of data: Graff-Radford, Parisi, Dickson, Giannini, Boeve.

Drafting of the manuscript: Graff-Radford.

Critical revision of the manuscript for important intellectual content: All authors.

Administrative, technical, or material support: Parisi, Giannini, Boeve.

Study supervision: Josephs, Parisi, Giannini, Boeve.

Conflict of Interest Disclosures: None reported.

Funding/Support: This study was funded by grant P50 AG16574 from the National Institutes of Health.

Role of the Funder/Sponsor: The National Institutes of Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Figures in this Article

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1.
Neuropsychologic Testing and Magnetic Resonance Imaging

A, All raw scores were converted to scaled scores based on Mayo Older American Normative Studies (MOANS) norms (mean [SD], 10 [3]). AVLT delay indicates retention on the Auditory Verbal Learning Test; BNT, Boston Naming Test; Categ, category; DRS, Dementia Rating Scale; Flu, Fluency; JLO, Judgment of Line Orientation; Rey-O, Rey-Osterrieth Complex Figure Test; TMT, Trail Making Test; WAIS-BD, Block Design subtest of the Wechsler Adult Intelligence Scale–Revised; WMS-LM-R, Logical Memory of the Wechsler Memory Scale–Revised; Stroop CW, Stroop color-word test. B, Coronal T1-weighted magnetic resonance images of the patient in her early 70s showing continued disproportional left anterior temporal lobe atrophy.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Histopathology Demonstrating Globular Glial Tauopathy

Globular glial tauopathy, type I, with 4R tau–positive globular glial inclusions, predominantly oligodendroglial and to a lesser extent astrocytic. The Gallyas stain was positive in oligodendroglial and negative in astrocytic lesions, as is typical of globular glial tauopathy. There were no TAR DNA-binding protein 43–positive inclusions. A, Temporal white matter (hematoxylin-eosin; original magnification ×200; inset ×750); B, temporal white matter (phospho-tau [AT8]; original magnification ×200); C, temporal gray matter (phospho-tau [AT8]; original magnification ×200; inset: 4R tau ×400); D, temporal white matter (Gallyas; original magnification ×200; inset ×750); E, temporal white matter (4R tau; original magnification ×200); and F, temporal gray matter (Gallyas; original magnification ×200).

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

475 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();